Sign Out
The safety of SKYCellflu Quadrivalent in pregnant women and breast-feeding women has not been assessed in clinical trials.
Pregnant women: Direct and/or indirect adverse effect related to reproduction and developmental toxicity was not observed in animal studies. Because of the consequences of influenza infection in pregnant women, WHO recommends vaccination of pregnant women.
Breast-feeding women: Since it is not known whether SKYCellflu Quadrivalent is excreted in breast milk, caution should be exercised when SKYCellflu Quadrivalent is administered to a nursing mother.
Fertility: No human fertility data are available. Animal data have not shown effects on female fertility. Male fertility has not been assessed in animals.
